For decades, migraine was mischaracterized as a simple "vascular headache" caused entirely by the dilation and contraction of blood vessels in the scalp and brain
CGRP is a potent neuropeptide widely distributed throughout the central and peripheral nervous systems, with particularly high concentrations in the trigeminal ganglion
Once released, CGRP binds to specific receptor complexes located on smooth muscle cells of meningeal blood vessels and nearby mast cells
Neurogenic Inflammation: CGRP causes local blood vessels to dilate and prompts surrounding immune cells to release inflammatory mediators
. This creates a state of localized neurogenic inflammation . Sensitization of Pain Pathways: CGRP amplifies pain signaling along the trigeminovascular pathway to the brain stem and higher cortical centers
. This sensitization drives classic migraine features, including throbbing pain, photophobia, phonophobia, and nausea .
Clinical studies confirmed CGRP's central role by measuring peptide levels during spontaneous attacks
These findings made CGRP receptor antagonists a major target for drug developers